EU’s legal pursuit of AstraZeneca looks short-sighted

Only semi-guaranteed outcome is that big pharma will never again agree to work for no profit during a pandemic

It’s been hard to keep up with the European commission and EU leaders’ changing stances on the Oxford/AstraZeneca coronavirus vaccine. But the ferocity of complaints about delayed deliveries seemed to have lessened in recent weeks. When Angela Merkel, the German chancellor, had her first dose of the product last week, she thanked everyone who was involved in the vaccination campaign.

News that the commission is about to sue AstraZeneca for its failure to deliver promised doses to the bloc takes things back to the bitterness of January. Stephen Donnelly, Ireland’s health minister, spoke in the Irish parliament on Thursday about the company’s “complete failure” to meet contractual agreements and said the country would be joining the legal action.

Continue reading…